BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18031327)

  • 1. Induction of hepatic 11beta-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease.
    Ahmed A; Saksena S; Sherlock M; Olliff SP; Elias E; Stewart PM
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):898-903. PubMed ID: 18031327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.
    Stewart PM; Burra P; Shackleton CH; Sheppard MC; Elias E
    J Clin Endocrinol Metab; 1993 Mar; 76(3):748-51. PubMed ID: 8445034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
    Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11beta-hydroxysteroid dehydrogenase activity in acromegalic patients with normal or impaired carbohydrate metabolism.
    Mondok A; Varga I; Glaz E; Szucs N; Tóth M; Patocs A; Beko G; Racz K
    Steroids; 2009 Sep; 74(9):725-9. PubMed ID: 19540999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK; Pedersen SB; Fisker S; Richelsen B
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM; Toogood AA; Tomlinson JW
    Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle.
    Jang C; Obeyesekere VR; Dilley RJ; Alford FP; Inder WJ
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):800-5. PubMed ID: 17121533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
    Draper N; Stewart PM
    J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver.
    Quinkler M; Jussli J; Bähr V; Pfeiffer AF; Lepenies J; Diederich S
    Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK; Nielsen MP; Richelsen B; Bruun JM; Flyvbjerg A; Pedersen SB
    Obesity (Silver Spring); 2008 Apr; 16(4):731-5. PubMed ID: 18379559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts.
    Yang Z; Guo C; Zhu P; Li W; Myatt L; Sun K
    J Endocrinol; 2007 Nov; 195(2):241-53. PubMed ID: 17951535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children.
    Mericq V; Medina P; Bouwman C; Johnson MC; Godoy J; López T; Iñiguez G
    Horm Res; 2009; 71(2):89-93. PubMed ID: 19129713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease.
    Ahmed A; Rabbitt E; Brady T; Brown C; Guest P; Bujalska IJ; Doig C; Newsome PN; Hubscher S; Elias E; Adams DH; Tomlinson JW; Stewart PM
    PLoS One; 2012; 7(2):e29531. PubMed ID: 22363403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative real-time PCR for the measurement of 11beta-HSD1 and 11beta-HSD2 mRNA levels in tissues of healthy dogs.
    Sieber-Ruckstuhl NS; Meli ML; Boretti FS; Gönczi E; Lutz H; Reusch CE
    Horm Metab Res; 2007 Aug; 39(8):548-54. PubMed ID: 17712718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
    Stegk JP; Ebert B; Martin HJ; Maser E
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):104-8. PubMed ID: 19022342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice.
    Alberts P; Engblom L; Edling N; Forsgren M; Klingström G; Larsson C; Rönquist-Nii Y; Ohman B; Abrahmsén L
    Diabetologia; 2002 Nov; 45(11):1528-32. PubMed ID: 12436336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.